
floatz is an AI-driven drug discovery platform that provides end-to-end R&D services to accelerate therapeutic development by translating complex biomedical data into validated targets and strategic intelligence. It offers novel target identification, target validation and prioritization, mechanism and pathway elucidation, preclinical candidate assessment, and biomarker and clinical intelligence. The platform integrates vast biomedical data sources using AI to uncover non-obvious patterns, with PhD-level experts curating the insights to produce decision-ready reports. This combination of AI and expert curation helps biotech and pharmaceutical companies de-risk pipelines and speed up development timelines. floatz partners with ETH AI Center and Microsoft for Startups, positioning itself as a scientifically rigorous and collaborative player in biotech AI.

floatz is an AI-driven drug discovery platform that provides end-to-end R&D services to accelerate therapeutic development by translating complex biomedical data into validated targets and strategic intelligence. It offers novel target identification, target validation and prioritization, mechanism and pathway elucidation, preclinical candidate assessment, and biomarker and clinical intelligence. The platform integrates vast biomedical data sources using AI to uncover non-obvious patterns, with PhD-level experts curating the insights to produce decision-ready reports. This combination of AI and expert curation helps biotech and pharmaceutical companies de-risk pipelines and speed up development timelines. floatz partners with ETH AI Center and Microsoft for Startups, positioning itself as a scientifically rigorous and collaborative player in biotech AI.